Market news

Detailed price information for Merck & Company (MRK-N) from The Globe and Mail including charting and trades.

Envista Holdings (NVST) is set to present at the 2026 Global Healthcare Conference in New York on September 15, giving investors fresh commentary to weigh against recent share performance and fundamentals. Envista Holdings enters the conference with mixed momentum, with the share price up 8.02% year to date but a 30 day share price return down 13.86%, and longer term total shareholder returns of 12.16% over one year and a decline of 44.86% over five years. Compare Envista Holdings with a...

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Detailed price information for Surgery Partners CS (SGRY-Q) from The Globe and Mail including charting and trades.

Envista (NVST) stock volatility following its investor day reflects investor expectations against th

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2026 Global Healthcare Conference. The fireside chat will take place on Tuesday, September 15, 2026, from 9:40 – 10:10 AM ET.

Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Envista Holdings Corp. (NYSE:NVST) shares rose 2.

Envista (NVST) has an average rating of overweight and mean price target of $29.43, according to ana

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Dollar General, Envista, Match Group and Allstate stand out as PEG-based value picks as investors seek opportunities beyond AI stocks.

Over the past six months, Envista’s shares (currently trading at $27.36) have posted a disappointing 7.6% loss, well below the S&P 500’s 10.5% gain. This may have investors wondering how to approach the situation.

Envista (NVST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Investors need to pay close attention to NVST stock based on the movements in the options market lately.

Envista Holdings (NVST) has combined its top leadership roles, with President and Chief Executive Officer Paul Keel also appointed Chair of the Board as of 19 August 2026, while Scott Huennekens becomes Lead Independent Director. See our latest analysis for Envista Holdings. Envista Holdings shares trade at US$26.93 after a recent 1 day share price return that declined 2.36%, although the 90 day share price return of 14.94% and 1 year total shareholder return of 31.62% indicate momentum has...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Envista , Reliance, The Ensign, The Hanover Insurance and Lenovo have been highlighted in this Screen of The Week article.

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Envista’s second quarter results were shaped by balanced growth across all major geographies and a continued focus on operational execution. Management pointed to resilient demand for dental care, especially in consumables and diagnostics, as a stabilizing influence despite macroeconomic uncertainty. CEO Paul Keel highlighted that new product launches in endodontics and orthodontics supported share gains, while margin expansion was driven by manufacturing productivity and cost control initiative

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

PEG-focused value picks Envista, Sanmina, TAL Education and Avient combine discounted valuations with solid long-term growth prospects.

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Examine the evolution of Envista's (NVST) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Envista Holdings Corporation recently reported Q2 2026 results showing higher sales of US$730.5 million and net income of US$53.7 million, with earnings per share from continuing operations rising to US$0.33. Alongside these results, Envista completed share repurchases totaling 12,458,894 shares for US$250 million, while also raising its full-year 2026 guidance despite expected pricing pressure in China. Now we will examine how Envista’s raised full-year guidance and earnings momentum...

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.